NASDAQ:PASG

Passage Bio Stock Insider Trading

Healthcare > Biotechnology

Buy PASG

*Your capital is at risk

$5.97

+0.0750 (+1.27%)

At Close: Jun 03, 2026

Passage Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 36.45. In total, the insiders bought 7.11M and sold 3.47M PASG shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	36.45
● Buy	7.11M shares
● Sell	3.47M shares
54% Buy Activity Moderate Positive Correlation
Buy Signal Medium Confidence Mar 16, 2026 Analysis Breakdown: Supported by a positive Insider Power Score of 36.45. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 22, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	78 049 Value: $26.5K
Apr 22, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	78 049 Value: $26.5K
Apr 17, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	77 090 Value: $25.4K
Apr 17, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	77 090 Value: $25.4K
Apr 16, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	61 638 Value: $20.3K
Apr 16, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	61 638 Value: $20.3K
Apr 15, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	10 326 Value: $4K
Apr 15, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	10 326 Value: $4K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Borthwick Kathleen CFO	C-Suite Officer	278 386 Value: $107.7K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Chou William President And CEO	CEO / President	779 533 Value: $301.7K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Cale Edgar B. GC & Corporate Secretary	Officer	278 386 Value: $107.7K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Cale Edgar B. GC & Corporate Secretary	Officer	278 386 Value: $107.7K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Chou William President And CEO	CEO / President	779 533 Value: $301.7K
Mar 15, 2025 Buy	Employee Stock Option (right to buy) A-Award	Borthwick Kathleen CFO	C-Suite Officer	278 386 Value: $107.7K
Feb 11, 2025 Sell	Common Stock S-Sale	Borthwick Kathleen CFO	C-Suite Officer	3 183 Value: $2K
Feb 11, 2025 Sell	Common Stock S-Sale	Borthwick Kathleen CFO	C-Suite Officer	3 183 Value: $2K
Feb 10, 2025 Buy	Common Stock M-Exempt	Borthwick Kathleen CFO	C-Suite Officer	8 000 Value: $5K
Feb 10, 2025 Buy	Restricted Stock Unit M-Exempt	Borthwick Kathleen CFO	C-Suite Officer	8 000 Value: $5K
Feb 10, 2025 Buy	Restricted Stock Unit M-Exempt	Borthwick Kathleen CFO	C-Suite Officer	8 000 Value: $5K
Feb 10, 2025 Buy	Common Stock M-Exempt	Borthwick Kathleen CFO	C-Suite Officer	8 000 Value: $5K
Jan 15, 2025 Buy	Restricted Stock Unit A-Award	Chou William President And CEO	CEO / President	20 000 Value: $11.7K
Jan 15, 2025 Buy	Restricted Stock Unit A-Award	Borthwick Kathleen CFO	C-Suite Officer	10 000 Value: $6K
Jan 14, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	79 024 Value: $47.4K
Jan 14, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	79 024 Value: $47.4K
Jan 13, 2025 Sell	Common Stock S-Sale	Orbimed Advisors Llc 10 Percent Owner	10% Owner	17 986 Value: $11.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PASSAGE BIO, INC.

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the...

Read Full Profile Here